Annicka Reuß
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 3
-
- COVID-19 epidemiological studies 3
- Co-authors
- Tim EckmannsNiklas WillrichRobby MarkwartOlaniyi AyobamiGuido WernerInes NollMarcel FeigWalter Haas
In The Last Decade
Annicka Reuß
27 papers receiving 616 citations
Peers
Comparison fields: 5 of 85
- Applied Microbiology and Biotechnology 65
- Molecular Medicine 117
- Clinical Biochemistry 107
- Infectious Diseases 249
- Epidemiology 322
Countries citing papers authored by Annicka Reuß
This map shows the geographic impact of Annicka Reuß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annicka Reuß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annicka Reuß more than expected).
Fields of papers citing papers by Annicka Reuß
This network shows the impact of papers produced by Annicka Reuß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annicka Reuß. The network helps show where Annicka Reuß may publish in the future.
Co-authors
The 25 scholars most cited alongside Annicka Reuß, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2022 | 4 | |
| 3 | 2021 | 20 | |
| 4 | 2021 | 37 | |
| 5 | 2021 | 0 | |
| 6 | 2020 | 103 | |
| 7 | 2020 | 4 | |
| 8 | 2020 | 2 | |
| 9 | 2019 | 88 | |
| 10 | 2016 | 7 | |
| 11 | 2016 | 25 | |
| 12 | 2015 | 44 | |
| 13 | 2013 | 2 | |
| 14 | 2011 | 17 | |
| 15 | Pandemieplanung: Was haben wir aus der Pandemie (H1N1) 2009 gelernt? | 2010 | 0 |
| 16 | 2010 | 20 | |
| 17 | 2010 | 12 | |
| 18 | 2010 | 7 | |
| 19 | 2010 | 22 | |
| 20 | 2009 | 41 |
About Annicka Reuß
Annicka Reuß is a scholar working on Applied Microbiology and Biotechnology, Modeling and Simulation, Epidemiology, Molecular Medicine and Infectious Diseases, having authored 30 papers that have together received 634 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (9 papers), Respiratory viral infections research (8 papers), Pneumonia and Respiratory Infections (5 papers), COVID-19 epidemiological studies (3 papers), Tuberculosis Research and Epidemiology (3 papers), Antibiotic Use and Resistance (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Mycobacterium research and diagnosis (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (65 citations), Molecular Medicine (117 citations), Clinical Biochemistry (107 citations), Infectious Diseases (249 citations) and Epidemiology (322 citations). Annicka Reuß has collaborated with scholars based in Germany, Portugal and Spain. Frequent co-authors include Tim Eckmanns, Niklas Willrich, Robby Markwart, Olaniyi Ayobami, Guido Werner, Ines Noll, Marcel Feig, Walter Haas, Sebastian Haller and Uwe Koppe. Their work appears in journals such as Antimicrobial Resistance and Infection Control, The Pediatric Infectious Disease Journal, Vaccine, BMC Public Health and Eurosurveillance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.